Dexa Group has once again demonstrated excellence at the Indonesia Public Relations Awards (IPRA) 2025, securing the Best Public Relations in Healthcare category. The award, presented by Warta Ekonomi, was given on Friday, January 24, 2025, in Jakarta.
This recognition underscores Dexa Group’s success in maintaining its corporate reputation through adaptive, innovative, and consistent communication strategies.
Seventh Award, Unwavering Dedication
This marks the seventh time Dexa Group has received the IPRA award and its first achievement in 2025. The award was presented by Warta Ekonomi CEO Mr. Muhamad Ihsan to Mr. Sonny Himawan, Head of Corporate Communications Dexa Group.
Dexa Group CEO Mr. Ferry Soetikno expressed appreciation for the team’s collective efforts.
“We are truly grateful for this recognition. It reflects the positive reputation we have built together through the hard work and dedication of every Dexan. Thank you to the entire team for their contributions,” he said.
Public Relations in the Digital Disruption Era
In today’s fast-evolving digital landscape, the role of public relations has become increasingly strategic. Mr. Muhamad Ihsan, CEO of Warta Ekonomi, highlighted that communication disruptions driven by technology and social media pose significant challenges for businesses.
“In the midst of communication disruptions, public relations plays a crucial role in maintaining trust and corporate image. Dexa Group has successfully navigated these challenges,” he stated.
Data from Indonesia’s Ministry of Communication and Digital Affairs recorded 1,923 hoax-related content in 2024, with the impact of misinformation on corporate reputation increasing by 35% compared to the previous year. This underscores the need for companies to be more agile in protecting their reputation in the public relations landscape.
Consistency Rooted in Core Values
According to Mr. Sonny Himawan, this award is a testament to Dexa Group’s strong corporate culture.
“Guided by our core purpose, Expertise for the Promotion of Health, and our corporate core values, every Dexan has contributed their best efforts. We hope Dexa Group continues to support pharmaceutical independence, advance Indonesian Modern Medicine, uphold sustainability principles (ESG), and remain committed to providing high-quality, effective, and safe medicines,” he stated.
This achievement serves as motivation for Dexa Group to continue making meaningful contributions to Indonesian society and the healthcare industry in a sustainable manner.